Mackenzie Financial’s CRH Medical Corporation CRHM Stock Holding History

Mackenzie Financial’s Portfolio CRHM Stock Details CRHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-129,350	Closed	-$171K	–	1175
2020 Q1	$171K	Buy	+129,350	New	+$423K	﹤0.01%	990
2019 Q1	–	Sell	-463,280	Closed	-$1.41M	–	1350
2018 Q4	$1.41M	Buy	+463,280	New	+$1.53M	﹤0.01%	757
2017 Q3	–	Sell	-211,300	Closed	-$1.2M	–	680
2017 Q2	$1.2M	Sell	211,300 -74,200	-26%	-$482K	0.01%	430
2017 Q1	$2.34M	Buy	285,500 +36,200	+15%	+$250K	0.01%	383
2016 Q4	$1.33M	Sell	249,300 -323,700	-56%	-$1.64M	0.01%	419
2016 Q3	$2.18M	Buy	573,000 +87,300	+18%	+$334K	0.01%	321
2016 Q2	$1.9M	Buy	+485,700	New	+$1.59M	0.01%	446
2016 Q1	–	Sell	-460,608	Closed	-$1.37M	–	905
2015 Q4	$1.37M	Buy	+460,608	New	+$1.28M	0.01%	480

Other funds holding CRHM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

SCM

Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mackenzie Financial's CRHM Position: Q2 2020 in Review

Mackenzie Financial sold out of CRH Medical Corporation (CRHM) in Q2 2020, closing a stake of 129,350 shares — an estimated $171K sold.

Mackenzie Financial first reported a position in CRHM in Q4 2015 and held it in 8 quarters. The position peaked at $2.34M in Q1 2017. 44 funds tracked by Wall St. Rank hold CRHM as of Q2 2020.

Mackenzie Financial reported no remaining CRH Medical Corporation position as of Q2 2020 after selling out during the quarter.
Mackenzie Financial sold 129,350 CRH Medical Corporation shares in Q2 2020, an estimated $171K.
Mackenzie Financial first reported a position in CRH Medical Corporation in Q4 2015 and held it in 8 quarters.
Mackenzie Financial's CRH Medical Corporation position peaked at $2.34M in Q1 2017.
44 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2020.

Based on Mackenzie Financial's 13F filing for Q2 2020, filed 13 Aug 2020.